CROSSROADS STRATEGIES, LLC

Lobbying for VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA AG · global pharmaceutical company

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 20, 2025

Income

$50,000.00

What the client paid this registrant for the period.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Medicare/Medicaid

General education about end stage renal disease (ESRD) and kidney disease policies, including Medicare beneficiary access to pharmaceuticals.

Health Issues

General education about end stage renal disease (ESRD) and kidney disease policies.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.